August 11, 2020 NEW YORK and SHANGHAI, China — Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose...
June 12, 2020 The clinical-stage ophthalmic biopharmaceutical company Eyenovia is developing a microdose treatment that is designed to improve the delivery of...